Advanced search
Publication Cover
Leukemia & Lymphoma Volume 61, 2020 - Issue 14
Submit an article Journal homepage
106
Views
0
CrossRef citations to date
0
Altmetric
Original Articles

Adjuvant chemotherapy administration and survival outcomes of lymphoma survivors with common solid tumors: a population-based study†

Mengyang Dia Department of Medicine, Alpert Medical School of Brown University, Providence, RI, USA;b Department of Medicine, Rhode Island Hospital, Providence, RI, USAORCID Iconhttps://orcid.org/0000-0001-6165-2617
ORCID Icon,
Orestis A. Panagiotouc Department of Health Services, Policy & Practice, Brown University School of Public Health, Providence, RI, USA;d Center for Gerontology & Healthcare Research, Brown University School of Public Health, Providence, RI, USAORCID Iconhttps://orcid.org/0000-0001-9604-8380
ORCID Icon,
John L. Reagana Department of Medicine, Alpert Medical School of Brown University, Providence, RI, USA;e Division of Hematology-Oncology, Rhode Island Hospital, Providence, RI, USAORCID Iconhttps://orcid.org/0000-0003-4877-6863
ORCID Icon,
Rabin Niroulaa Department of Medicine, Alpert Medical School of Brown University, Providence, RI, USA;e Division of Hematology-Oncology, Rhode Island Hospital, Providence, RI, USA
&
Adam J. Olszewskia Department of Medicine, Alpert Medical School of Brown University, Providence, RI, USA;e Division of Hematology-Oncology, Rhode Island Hospital, Providence, RI, USACorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-6472-6658
ORCID Icon
Pages 3360-3368 | Received 10 May 2020, Accepted 23 Aug 2020, Published online: 11 Sep 2020

References

  • National Cancer Institute Surveillance, Epidemiology, and End Results Program: SEER Cancer Statistics Review, 19752015. Available from: https://seer.cancer.gov/csr/1975_2015/.
  • Brenner H, Gondos A, Pulte D. Ongoing improvement in long-term survival of patients with Hodgkin disease at all ages and recent catch-up of older patients. Blood. 2008;111(6):2977–2983.
  • Ng AK, LaCasce A, Travis LB. Long-term complications of lymphoma and its treatment. J Clin Oncol. 2011;29(14):1885–1892.
  • Schaapveld M, Aleman BM, van Eggermond AM, et al. Second cancer risk up to 40 years after treatment for Hodgkin's lymphoma. N Engl J Med. 2015;373(26):2499–2511.
  • Swerdlow AJ, Higgins CD, Smith P, et al. Second cancer risk after chemotherapy for Hodgkin's lymphoma: a collaborative British cohort study. J Clin Oncol. 2011;29(31):4096–4104.
  • Bhakta N, Liu Q, Yeo F, et al. Cumulative burden of cardiovascular morbidity in paediatric, adolescent, and young adult survivors of Hodgkin's lymphoma: an analysis from the St Jude Lifetime Cohort Study. Lancet Oncol. 2016;17(9):1325–1334.
  • Eloranta S, Lambert PC, Sjoberg J, et al. Temporal trends in mortality from diseases of the circulatory system after treatment for Hodgkin lymphoma: a population-based cohort study in Sweden (1973 to 2006). J Clin Oncol. 2013;31(11):1435–1441.
  • Hershman DL, McBride RB, Eisenberger A, et al. Doxorubicin, cardiac risk factors, and cardiac toxicity in elderly patients with diffuse B-cell non-Hodgkin's lymphoma. J Cin Oncol. 2008;26(19):3159–3165.
  • Elkin EB, Klem ML, Gonzales AM, et al. Characteristics and outcomes of breast cancer in women with and without a history of radiation for Hodgkin's lymphoma: a multi-institutional, matched cohort study. J Clin Oncol. 2011;29(18):2466–2473.
  • Terenziani M, Massimino M, Magazzu D, et al. Management of breast cancer after Hodgkin's lymphoma and paediatric cancer. Eur J Cancer. 2015;51(13):1667–1674.
  • Sanna G, Lorizzo K, Rotmensz N, et al. Breast cancer in Hodgkin's disease and non-Hodgkin's lymphoma survivors. Ann Oncol. 2007;18(2):288–292.
  • Veit-Rubin N, Rapiti E, Usel M, et al. Risk, characteristics, and prognosis of breast cancer after Hodgkin's lymphoma. Oncologist. 2012;17(6):783–791.
  • Cunningham D, Atkin W, Lenz HJ, et al. Colorectal cancer. Lancet. 2010;375(9719):1030–1047.
  • Early Breast Cancer Trialists' Collaborative Group. Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials. Lancet Oncol. 2018;19:27–39.
  • Sangha R, Price J, Butts CA. Adjuvant therapy in non-small cell lung cancer: current and future directions. Oncologist. 2010;15(8):862–872.
  • Geskus RB. Cause-specific cumulative incidence estimation and the fine and gray model under both left truncation and right censoring. Biometrics. 2011;67(1):39–49.
  • Mulrooney DA, Yeazel MW, Kawashima T, et al. Cardiac outcomes in a cohort of adult survivors of childhood and adolescent cancer: retrospective analysis of the Childhood Cancer Survivor Study cohort. BMJ. 2009;339(dec08 1):b4606–b4606.
  • Mehta LS, Watson KE, Barac A, American Heart Association Cardiovascular Disease in Women and Special Populations Committee of the Council on Clinical Cardiology; Council on Cardiovascular and Stroke Nursing; and Council on Quality of Care and Outcomes Research, et al. Cardiovascular disease and breast cancer: where these entities intersect: a scientific statement from the American Heart Association. Circulation. 2018;137(8):e30–e66.
  • Youn P, Li H, Milano MT, et al. Long-term survival among Hodgkin's lymphoma patients with gastrointestinal cancer: a population-based study. Ann Oncol. 2013;24(1):202–208.
  • Rigter LS, Spaander MCW, Aleman BMP, et al. High prevalence of advanced colorectal neoplasia and serrated polyposis syndrome in Hodgkin lymphoma survivors. Cancer. 2019;125(6):990–999.
  • Guastadisegni C, Colafranceschi M, Ottini L, et al. Microsatellite instability as a marker of prognosis and response to therapy: a meta-analysis of colorectal cancer survival data. Eur J Cancer. 2010;46(15):2788–2798.
  • Rigter LS, Snaebjornsson P, Rosenberg EH, PALGA group, et al. Double somatic mutations in mismatch repair genes are frequent in colorectal cancer after Hodgkin's lymphoma treatment. Gut. 2018;67(3):447–455.
  • Healy MA, Morris AM, Abrahamse P, et al. The accuracy of chemotherapy ascertainment among colorectal cancer patients in the surveillance, epidemiology, and end results registry program. BMC Cancer. 2018;18(1):481.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.